<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>pathology</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>pathology | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Disease progression modelling reveals heterogeneity in trajectories of Lewy-type alpha-synuclein pathology
Authors: Mastenbroek, S. E.; Vogel, J. W.; Collij, L. E.; Serrano, G. E.; Tremblay, C.; Young, A. L.; Arce, R. A.; Shill, H. A.; Driver-Dunckley, E. D.; Mehta, S. H.; Belden, C. M.; Atri, A.; Choudhury, P.; Barkhof, F.; Adler, C. H.; Ossenkoppele, R.; Beach, T. G.; Hansson, O.
Score: 16.6, Published: 2023-12-07 DOI: 10.1101/2023.12.05.569878
Lewy body (LB) disorders, characterized by the aggregation of misfolded -synuclein proteins, exhibit notable clinical heterogeneity.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/pathology/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="pathology" />
<meta property="og:description" content="Disease progression modelling reveals heterogeneity in trajectories of Lewy-type alpha-synuclein pathology
Authors: Mastenbroek, S. E.; Vogel, J. W.; Collij, L. E.; Serrano, G. E.; Tremblay, C.; Young, A. L.; Arce, R. A.; Shill, H. A.; Driver-Dunckley, E. D.; Mehta, S. H.; Belden, C. M.; Atri, A.; Choudhury, P.; Barkhof, F.; Adler, C. H.; Ossenkoppele, R.; Beach, T. G.; Hansson, O.
Score: 16.6, Published: 2023-12-07 DOI: 10.1101/2023.12.05.569878
Lewy body (LB) disorders, characterized by the aggregation of misfolded -synuclein proteins, exhibit notable clinical heterogeneity." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/pathology/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-12-13T10:39:57+00:00" />
<meta property="article:modified_time" content="2023-12-13T10:39:57+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="pathology"/>
<meta name="twitter:description" content="Disease progression modelling reveals heterogeneity in trajectories of Lewy-type alpha-synuclein pathology
Authors: Mastenbroek, S. E.; Vogel, J. W.; Collij, L. E.; Serrano, G. E.; Tremblay, C.; Young, A. L.; Arce, R. A.; Shill, H. A.; Driver-Dunckley, E. D.; Mehta, S. H.; Belden, C. M.; Atri, A.; Choudhury, P.; Barkhof, F.; Adler, C. H.; Ossenkoppele, R.; Beach, T. G.; Hansson, O.
Score: 16.6, Published: 2023-12-07 DOI: 10.1101/2023.12.05.569878
Lewy body (LB) disorders, characterized by the aggregation of misfolded -synuclein proteins, exhibit notable clinical heterogeneity."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "pathology",
      "item": "https://trxiv.yorks0n.com/posts/pathology/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "pathology",
  "name": "pathology",
  "description": "Disease progression modelling reveals heterogeneity in trajectories of Lewy-type alpha-synuclein pathology\nAuthors: Mastenbroek, S. E.; Vogel, J. W.; Collij, L. E.; Serrano, G. E.; Tremblay, C.; Young, A. L.; Arce, R. A.; Shill, H. A.; Driver-Dunckley, E. D.; Mehta, S. H.; Belden, C. M.; Atri, A.; Choudhury, P.; Barkhof, F.; Adler, C. H.; Ossenkoppele, R.; Beach, T. G.; Hansson, O.\nScore: 16.6, Published: 2023-12-07 DOI: 10.1101/2023.12.05.569878\nLewy body (LB) disorders, characterized by the aggregation of misfolded -synuclein proteins, exhibit notable clinical heterogeneity.",
  "keywords": [
    
  ],
  "articleBody": " Disease progression modelling reveals heterogeneity in trajectories of Lewy-type alpha-synuclein pathology\nAuthors: Mastenbroek, S. E.; Vogel, J. W.; Collij, L. E.; Serrano, G. E.; Tremblay, C.; Young, A. L.; Arce, R. A.; Shill, H. A.; Driver-Dunckley, E. D.; Mehta, S. H.; Belden, C. M.; Atri, A.; Choudhury, P.; Barkhof, F.; Adler, C. H.; Ossenkoppele, R.; Beach, T. G.; Hansson, O.\nScore: 16.6, Published: 2023-12-07 DOI: 10.1101/2023.12.05.569878\nLewy body (LB) disorders, characterized by the aggregation of misfolded -synuclein proteins, exhibit notable clinical heterogeneity. This may be due to variations in accumulation patterns of LB neuropathology. By applying data-driven disease progression modelling to regional neuropathological LB density scores from 814 brain donors, we describe three inferred trajectories of LB pathology that were characterized by differing clinicopathological presentation and longitudinal antemortem clinical progression. Most donors (81.9%) showed earliest pathology in the olfactory bulb, followed by accumulation in either limbic (60.8%) or brainstem (21.1%) regions. The remaining donors (18.1%) exhibited the first abnormalities in brainstem regions. Early limbic pathology was associated with Alzheimers disease-associated characteristics. Meanwhile, brainstem-first pathology was associated with progressive motor impairment and substantial LB pathology outside of the brain. Our data provides evidence for heterogeneity in the temporal spread of LB pathology, possibly explaining some of the clinical disparities observed in LBDs.\nThe immunosuppressive Tuberculosis-associated microenvironment inhibits viral replication and promotes HIV-1 latency in CD4+ T cells\nAuthors: Cronin, S.; de Vries-Egan, A.; Vahlas, Z.; Czernikier, A.; Melucci, C.; Gerber, P. P.; ONeil, T.; Gloss, B.; Sharabas, M.; Turk, G.; Verollet, C.; Balboa, L.; Palmer, S.; Duette, G. A.\nScore: 1.4, Published: 2023-12-12 DOI: 10.1101/2023.12.05.570223\nMycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is the most common coinfection among people living with HIV-1. This coinfection alters the efficacy of the immune response against both HIV-1 and Mtb, and is associated with accelerated HIV-1 disease progression and reduced survival. Enhanced HIV-1 replication in macrophages induced by Mtb coinfection may contribute to the worsened clinical outcomes observed in HIV-1/TB coinfected individuals. However, the impact of the HIV-1/TB coinfection on HIV-1 replication and latency in CD4+ T cells remains poorly studied. In this study, we used the acellular fraction of tuberculous pleural effusion (TB-PE) as a proxy for the microenvironment generated by Mtb infection. Using this physiologically relevant fluid, we investigated whether viral replication and HIV-1 latency in CD4+ T cells are affected by a TB-associated microenvironment. Interestingly, our results revealed that TB-PE shaped the transcriptional profile of CD4+ T cells impairing T cell receptor-dependent cell activation and decreased HIV-1 replication. Moreover, this immunosuppressive TB microenvironment promoted viral latency and inhibited HIV-1 reactivation in CD4+ T cells from people living with HIV-1. This study indicates that the immune response induced by TB may contribute to the persistence of the viral reservoir by silencing HIV-1 expression in individuals coinfected with both pathogens, allowing the virus to persist undetected by the immune system and increasing the size of the HIV-1 latent reservoir in cells at the site of the coinfection.\n",
  "wordCount" : "495",
  "inLanguage": "en",
  "datePublished": "2023-12-13T10:39:57Z",
  "dateModified": "2023-12-13T10:39:57Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/pathology/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      pathology
    </h1>
    <div class="post-meta">&lt;span&gt;updated on December 13, 2023&lt;/span&gt;

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.12.05.569878">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.12.05.569878" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.12.05.569878">
        <p class="paperTitle">Disease progression modelling reveals heterogeneity in trajectories of Lewy-type alpha-synuclein pathology</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.12.05.569878" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.12.05.569878" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Mastenbroek, S. E.; Vogel, J. W.; Collij, L. E.; Serrano, G. E.; Tremblay, C.; Young, A. L.; Arce, R. A.; Shill, H. A.; Driver-Dunckley, E. D.; Mehta, S. H.; Belden, C. M.; Atri, A.; Choudhury, P.; Barkhof, F.; Adler, C. H.; Ossenkoppele, R.; Beach, T. G.; Hansson, O.</p>
        <p class="info">Score: 16.6, Published: 2023-12-07 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.12.05.569878' target='https://doi.org/10.1101/2023.12.05.569878'> 10.1101/2023.12.05.569878</a></p>
        <p class="abstract">Lewy body (LB) disorders, characterized by the aggregation of misfolded -synuclein proteins, exhibit notable clinical heterogeneity. This may be due to variations in accumulation patterns of LB neuropathology. By applying data-driven disease progression modelling to regional neuropathological LB density scores from 814 brain donors, we describe three inferred trajectories of LB pathology that were characterized by differing clinicopathological presentation and longitudinal antemortem clinical progression. Most donors (81.9%) showed earliest pathology in the olfactory bulb, followed by accumulation in either limbic (60.8%) or brainstem (21.1%) regions. The remaining donors (18.1%) exhibited the first abnormalities in brainstem regions. Early limbic pathology was associated with Alzheimers disease-associated characteristics. Meanwhile, brainstem-first pathology was associated with progressive motor impairment and substantial LB pathology outside of the brain. Our data provides evidence for heterogeneity in the temporal spread of LB pathology, possibly explaining some of the clinical disparities observed in LBDs.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.12.05.570223">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.12.05.570223" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.12.05.570223">
        <p class="paperTitle">The immunosuppressive Tuberculosis-associated microenvironment inhibits viral replication and promotes HIV-1 latency in CD4&#43; T cells</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.12.05.570223" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.12.05.570223" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Cronin, S.; de Vries-Egan, A.; Vahlas, Z.; Czernikier, A.; Melucci, C.; Gerber, P. P.; ONeil, T.; Gloss, B.; Sharabas, M.; Turk, G.; Verollet, C.; Balboa, L.; Palmer, S.; Duette, G. A.</p>
        <p class="info">Score: 1.4, Published: 2023-12-12 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.12.05.570223' target='https://doi.org/10.1101/2023.12.05.570223'> 10.1101/2023.12.05.570223</a></p>
        <p class="abstract">Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is the most common coinfection among people living with HIV-1. This coinfection alters the efficacy of the immune response against both HIV-1 and Mtb, and is associated with accelerated HIV-1 disease progression and reduced survival. Enhanced HIV-1 replication in macrophages induced by Mtb coinfection may contribute to the worsened clinical outcomes observed in HIV-1/TB coinfected individuals. However, the impact of the HIV-1/TB coinfection on HIV-1 replication and latency in CD4&#43; T cells remains poorly studied. In this study, we used the acellular fraction of tuberculous pleural effusion (TB-PE) as a proxy for the microenvironment generated by Mtb infection. Using this physiologically relevant fluid, we investigated whether viral replication and HIV-1 latency in CD4&#43; T cells are affected by a TB-associated microenvironment. Interestingly, our results revealed that TB-PE shaped the transcriptional profile of CD4&#43; T cells impairing T cell receptor-dependent cell activation and decreased HIV-1 replication. Moreover, this immunosuppressive TB microenvironment promoted viral latency and inhibited HIV-1 reactivation in CD4&#43; T cells from people living with HIV-1. This study indicates that the immune response induced by TB may contribute to the persistence of the viral reservoir by silencing HIV-1 expression in individuals coinfected with both pathogens, allowing the virus to persist undetected by the immune system and increasing the size of the HIV-1 latent reservoir in cells at the site of the coinfection.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        · Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
